NCT07765173 Muscle Function Following Anterior Cruciate Ligament Reconstruction: Impaired Power Output in Physically Active Individuals
| NCT ID | NCT07765173 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Metropole Savoie |
| Condition | ACL Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2026-06-08 |
| Primary Completion | 2030-06-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2026-06-08 with a primary completion date of 2030-06-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to to determine the extent of the association between objective changes in the muscle function of the knee extensors (strength and power) and the function reported by the patient following ACL reconstruction surgery. The main questions it aims to answer is: \- Pre- and post-operative (6 months) changes in maximum knee extensor strength following ACL reconstruction, correlated with the IKDC-SKF score.
Eligibility Criteria
Inclusion Criteria: * Patients requiring isolated or complex ACL reconstruction (combined with a meniscal injury) * Patients who are physically active (Tegner score ≥ 4) and wish to resume such activity. * Patients with no history of surgery on the ipsilateral knee (i.e., native knee). * Patients able to comply with the study procedures * Patients who have given their free and informed written consent, having been informed of the purpose of the study, its procedure and its risks. * Be affiliated to a social security scheme. Exclusion Criteria: * Patient with comprehension difficulties * Recurrent rupture of the ipsilateral ACL * Multi-ligament injuries (i.e., injury to the medial collateral ligament, lateral collateral ligament or posterior cruciate ligament)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07765173 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying ACL Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07765173 currently recruiting?
Yes, NCT07765173 is actively recruiting participants. Contact the research team at leo.blervaque@ch-metropole-savoie.fr for enrollment information.
Where is the NCT07765173 trial being conducted?
This trial is being conducted at Challes-les-Eaux, France.
Who is sponsoring the NCT07765173 clinical trial?
NCT07765173 is sponsored by Centre Hospitalier Metropole Savoie. The trial plans to enroll 110 participants.